Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Ryuta Uraki, Aaron Rico, Maki Kiso et al.|Nature|2022Cited by 292
Characterization of a new SARS-CoV-2 variant that emerged in BrazilMasaki Imai, Tsuguto Fujimoto, Peter Halfmann et al.|Proceedings of the National Academy of Sciences|2021Cited by 87
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024William G. Wierda, Mary A. Dwyer, Larry D. Cripe et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 83
PARIS and SPARTA: Finding the Achilles’ Heel of SARS-CoV-2Viviana Simon, Florian Krammer, Vamsi Kota et al.|mSphere|2022Cited by 36